Document Detail


Chlorozotocin (DCNU)--induced pulmonary toxicity.
MedLine Citation:
PMID:  6459189     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A case of pulmonary toxicity after chlorozotocin (DCNU) is described. This patient developed shortness of breath, nonproductive cough, and interstitial infiltrates after his third dose of DCNU. This was documented on pulmonary function tests which showed a reduction in vital capacity and pulmonary diffusion capacity. Similar findings have been reported in restrictive pulmonary disease associated with other nitrosoureas. This is the first case reported of pulmonary toxicity induced by DCNU.
Authors:
E M Sordillo; P P Sordillo; D Stover; G B Magill
Related Documents :
3677629 - The effect of blood flow and diffusion impairment on pulmonary gas exchange: a computer...
4082089 - Immunodetection of human fibrin using monoclonal antibody-64c5 in an extracorporeal chi...
17027629 - An unintended consequence: fatal amiodarone pulmonary toxicity in an older woman.
18252919 - Pulmonary complications of novel antineoplastic agents for solid tumors.
7302629 - Ventilation-perfusion imaging and pulmonary angiography: changing pattern of use.
10600099 - Amiodarone-induced pulmonary toxicity.
17267899 - Postpartum rupture of an intracranial aneurysm.
20802419 - Successful endoscopic clipping for bleeding from colonic angiodysplasia in a case of he...
16643319 - Lesion patterns and etiology of ischemia in the anterior inferior cerebellar artery ter...
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Cancer clinical trials     Volume:  4     ISSN:  0190-1206     ISO Abbreviation:  Cancer Clin Trials     Publication Date:  1981  
Date Detail:
Created Date:  1982-03-22     Completed Date:  1982-03-22     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  7905482     Medline TA:  Cancer Clin Trials     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  397-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Fibrosarcoma / drug therapy*,  secondary
Humans
Lung Neoplasms / drug therapy*,  secondary
Male
Middle Aged
Pulmonary Fibrosis / chemically induced*
Respiratory Function Tests
Streptozocin / adverse effects,  analogs & derivatives*,  therapeutic use
Grant Support
ID/Acronym/Agency:
1-CM-57043/CM/NCI NIH HHS; CA-05826/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
18883-66-4/Streptozocin; 54749-90-5/chlorozotocin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Myocardial blood flow and mechanics in volume overload-induced left ventricular hypertrophy in dogs.
Next Document:  A controlled clinical and immunological evaluation of immunotherapy with Bacillus Calmette--Guerin i...